# Preliminary Launch Strategic Imperatives

**Launch -12 Months to Launch**

**Confidential. For internal purposes only.**

---

## Strategic Imperatives Overview

### 1. Activate and Empower the PBH Community
*through education, awareness and advocacy*

### 2. Challenge the Slow-Adoption Mindset in Endo
*with deep urgency and strong evidence*

### 3. Accelerate Patient Journey toward Endo and COE
*in order to effectively connect PLWPBH to avexitide treatment*

### 4. Enable Broad Access & Utilization
*with buy-in from payers and high-value services offerings*

---

## Detailed Strategic Imperatives

### Imperative 1: Activate and Empower the PBH Community
*through education, awareness and advocacy*

**Strategy:**
Connect with the community's strong desire to control their PBH by empowering PLwPBH to engage with their care team about avexitide as a potential treatment option and land with the right prescriber

**Objectives:**
1. Enhance awareness of PBH and treatment options
2. Empower PLwPBH to advocate for diagnosis and their own care
3. Build a community of PBH advocates and champions

---

### Imperative 2: Challenge the Slow-Adoption Mindset in Endo
*with deep urgency and strong evidence*

**Strategy:**
Leverage avexitide's "first and only" status to generate quick wins with early-adopter segments, while laying a foundation for long-term success in lagging segments

**Objectives:**
1. Demonstrate clinical differentiation and the value of avexitide for PBH
2. Win consensus about avexitide's role in the treatment paradigm
3. Leverage KOL advocacy and positive word-of-mouth to influence avexitide trial and utilization

---

### Imperative 3: Accelerate Patient Journey toward Endo and COE
*in order to effectively connect PLWPBH to avexitide treatment*

**Strategy:**
Navigate a diffuse market by applying innovative data and technology solutions to identify key opportunities and maximize engagement within personal and non-personal channels

**Objectives:**
1. Use AI and machine learning to identify PLwPBH and their treaters
2. Implement an effective multi-channel approach; focus on digital excellence
3. Pilot innovative, scalable ideas to secure key segments and create long-term opportunity

---

### Imperative 4: Enable Broad Access & Utilization
*with buy-in from payers and high-value services offerings*

**Strategy:**
Make access to avexitide possible by securing broad coverage based on its unique value proposition and by supporting PLwPBH with services that maximize access and adherence

**Objectives:**
1. Drive understanding of value proposition with payers
2. Help patients and HCPs overcome access barriers through financial support options and other patient services offerings
